Rockwell Medical (RMTI) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 41.72% |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | 57.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.60% |
| Dec 31, 2025 | 43.28% |
| Sep 30, 2025 | 28.32% |
| Jun 30, 2025 | 51.95% |
| Mar 31, 2025 | 41.44% |
| Dec 31, 2024 | 39.28% |
| Sep 30, 2024 | 33.45% |
| Jun 30, 2024 | 27.86% |
| Mar 31, 2024 | 37.42% |
| Dec 31, 2023 | 69.23% |
| Sep 30, 2023 | 27.88% |
| Jun 30, 2023 | 16.82% |
| Mar 31, 2023 | 42.92% |
| Dec 31, 2022 | 75.42% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | 22.91% |
| Mar 31, 2022 | 9.97% |
| Sep 30, 2021 | 5.79% |
| Jun 30, 2021 | 11.76% |
| Dec 31, 2020 | -13.15% |